First Time Loading...

Celldex Therapeutics Inc
NASDAQ:CLDX

Watchlist Manager
Celldex Therapeutics Inc Logo
Celldex Therapeutics Inc
NASDAQ:CLDX
Watchlist
Price: 38.21 USD -4.33% Market Closed
Updated: May 18, 2024

Celldex Therapeutics Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Celldex Therapeutics Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Celldex Therapeutics Inc
NASDAQ:CLDX
Operating Expenses
-$148.9m
CAGR 3-Years
-41%
CAGR 5-Years
-21%
CAGR 10-Years
-6%
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$19.5B
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$12.1B
CAGR 3-Years
9%
CAGR 5-Years
-6%
CAGR 10-Years
-11%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$12.5B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.8B
CAGR 3-Years
-22%
CAGR 5-Years
-19%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.3B
CAGR 3-Years
-22%
CAGR 5-Years
-15%
CAGR 10-Years
-19%

See Also

What is Celldex Therapeutics Inc's Operating Expenses?
Operating Expenses
-148.9m USD

Based on the financial report for Dec 31, 2023, Celldex Therapeutics Inc's Operating Expenses amounts to -148.9m USD.

What is Celldex Therapeutics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-6%

Over the last year, the Operating Expenses growth was -45%. The average annual Operating Expenses growth rates for Celldex Therapeutics Inc have been -41% over the past three years , -21% over the past five years , and -6% over the past ten years .